Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Synthetic hair implants can cause severe scalp problems and removing them improves conditions; natural hair transplants are safer and more effective.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

The anti-ageing treatment market is growing by exploiting fears of ageing with unproven promises, which could harm public trust and genuine science.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

The digital system for measuring melasma shows promise but needs more development for better accuracy and automation.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

LLLT promotes hair growth and improves hair density safely in men and women.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Oral Apremilast effectively treats alopecia areata in most patients.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.

Both methods improve hair density and thickness; double-spin may be more effective.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.